Bacillus clausii
Product Description
Sanzyme Biologics
-
Country/Region:India
-
On CPHI since:2026
Sanzyme Biologics
-
Country/Region:India
-
On CPHI since:2026
More Products from Sanzyme Biologics (4)
-
Product L-Asparaginase & PEG-L-Asparaginase.
L-asparaginase is an enzyme derived from E.coli, crucial for cancer therapy, primarily utilized in treating acute lymphoblastic leukemia (ALL) and other related malignancies. By targeting and depleting asparagine, a critical amino acid for cancer cell survival, asparaginase disrupts the cancer cells' abili... -
Product Semaglutide & Precursor (P-29)
Semaglutide, a glucagon-like peptide-1 (GLP-1) analogue used to treat diabetes and long-term weight management. Semaglutide Precursor (P-29): The Recombinant P29 peptide is a critical intermediate in the synthesis of Semaglutide. P29 offers superior consistency, purity, and scalability compared to chemica... -
Product SNZ 1969®
SNZ 1969® is Sanzyme Biologics' flagship Bacillus coagulans probiotic, trusted globally for its unique combination of scientific validation, stability and formulation versatility. Backed by over 55 years of documented use, 35 clinical studies and consumption in more than 150 million doses annually across 4... -
Product Insulin Aspart.
Insulin aspart [rDNA origin] is a rapid-acting human insulin analog used to lower blood glucose. It is homologous with regular human insulin with the exception of a single substitution of the amino acid proline by aspartic acid in position B28, and is produced by recombinant DNA technology. Insulin aspart...
